Abound Wealth Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Abound Wealth Management’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.09K	Hold	4	–	–	﹤0.01%	810
2026 Q1	$1.44K	Hold	4	–	–	﹤0.01%	951
2025 Q4	$1.73K	Hold	4	–	–	﹤0.01%	869
2025 Q3	$1.65K	Buy	4 +1	+33%	+$407	﹤0.01%	831
2025 Q2	$979	Hold	3	–	–	﹤0.01%	805
2025 Q1	$811	Sell	3 -1	-25%	-$257	﹤0.01%	774
2024 Q4	$885	Buy	4 +1	+33%	+$263	﹤0.01%	749
2024 Q3	$826	Buy	+3	New	+$781	﹤0.01%	799
2024 Q2	–	Sell	-3	Closed	-$449	–	1175
2024 Q1	$449	Sell	3 -1	-25%	-$167	﹤0.01%	928
2023 Q4	$706	Buy	4 +1	+33%	+$170	﹤0.01%	845
2023 Q3	$532	Hold	3	–	–	﹤0.01%	796
2023 Q2	$570	Buy	+3	New	+$595	﹤0.01%	807

Other funds holding ALNY

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Assenagon Asset Management

Assenagon Asset Management Senningerberg, Luxembourg $77B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

PensionDanmark Copenhagen O, Denmark $12B AUM

E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return

Howland Capital Management Boston, Massachusetts $2.77B AUM 19.56% 1-Year Est. Return

Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return

Laurie J. Hall Trustee $322M AUM 33.73% 1-Year Est. Return

Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return